Broadley-James and Emerson Process Management are partnering to test bioreactor modeling techniques and tools to support the U.S. Food and Drug Administrations Process Analytical Technology (PAT) initiative. The model is intended to enable researchers to optimize manufacturing operations by evaluating a wide range of process alternatives in a fraction of the time and cost currently required. Live from Emerson Exchange, Walt Boyes, editor-in-chief of Control, discusses the projects potential with Scott Broadley, president of Broadley-James and Emerson Process Managements Terry Blevins.
Video duration: approximately 13 minutes and 8 seconds
